-
srdr.ahrq.gov/projects/1671/studies/196118
January 01, 2001 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196132
January 01, 2018 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196141
January 01, 2007 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196120
January 01, 2009 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196135
January 01, 2010 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196131
January 01, 2008 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196133
January 01, 2012 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196140
January 01, 2008 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196109
January 01, 2001 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196128
January 01, 2002 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196138
January 01, 2016 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196152
January 01, 2011 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196159
January 01, 2013 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
srdr.ahrq.gov/projects/1671/studies/196153
January 01, 2012 - What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or … nonpharmacologic therapy with respect to: (1) misuse, (2) overdose; (3) MOH, (4) other harms including … gastrointestinal-related harms, cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents, endocrinological harms, infections, cognitive harms, and psychological harms … How do harms vary depending on: (1) patient demographics (e.g. age, gender); (2) patient medical comorbidities
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
April 01, 2021 - • The paucity of evidence does not mean that pharmacotherapy is not beneficial, nor
that harms do … ; a systematic review will help
clarify the balance of benefits and harms. … As a result, most studies could not assert a causal
relationship between exposure and resultant harms … Regarding maternal harms, benzodiazepine before conception may
be associated with an increased risk … By contrast, evidence is voluminous but of low quality on the harms of
pharmacotherapy.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
April 01, 2021 - • The paucity of evidence does not mean that pharmacotherapy is not beneficial, nor
that harms do … ; a systematic review will help
clarify the balance of benefits and harms. … As a result, most studies could not assert a causal
relationship between exposure and resultant harms … Regarding maternal harms, benzodiazepine before conception may
be associated with an increased risk … By contrast, evidence is voluminous but of low quality on the harms of
pharmacotherapy.
-
psnet.ahrq.gov/node/61035/psn-pdf
October 21, 2020 - Children and the opioid epidemic: age-stratified
exposures and harms. … Children and the opioid epidemic: age-stratified exposures and
harms. … https://psnet.ahrq.gov/issue/children-and-opioid-epidemic-age-stratified-exposures-and-harms
Over the … Adolescents ages 15 to 17 years disproportionately experienced these harms
compared to younger age groups … https://psnet.ahrq.gov/issue/children-and-opioid-epidemic-age-stratified-exposures-and-harms
https://
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/4Y3fahSbgS2CJaj9HmJTYe
November 23, 2020 - For adults ages 76 to 85, the benefits and harms of screening depend on each person’s overall health … Harms from screening vary by test and can include more mild harms, such as inconvenience from preparing … The potential benefits and harms of screening tests vary. … They are based on the quality and strength of
the evidence about the potential benefits and harms of … They are also based on the size of the potential
benefits and harms.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/pancreatic-cancer-screening
August 06, 2019 - In 8 studies (n = 675) assessing procedural harms of screening, no serious harms from initial screening … Evidence of surgical harms was limited. … Harms of Screening
Key Question 3. … Harms of Treatment
Key Question 5. … Inconsistent, imprecise
Harms inconsistently reported, as were the methods of assessing harms
-
psnet.ahrq.gov/node/861777/psn-pdf
January 31, 2024 - Citing harms, momentum grows to remove race from
clinical algorithms.
January 31, 2024
Kuehn BM. … Citing harms, momentum grows to remove race from clinical algorithms. … https://psnet.ahrq.gov/issue/citing-harms-momentum-grows-remove-race-clinical-algorithms
Medical history … https://psnet.ahrq.gov/issue/citing-harms-momentum-grows-remove-race-clinical-algorithms
https://psnet.ahrq.gov